Track insider trading activity from Pfizer executives and directors. Pfizer Inc. stands as a global leader in pharmaceuticals and biotechnology, notably recognized for its role as a vaccine provider during the COVID-19 pandemic and its focus on innovative medicines in areas like cancer. Key insiders include CEO and Chairman Dr. Albert Bourla, Chief Corporate Affairs Officer Sally Susman, and various members of its Board of Directors such as Shantanu Narayen, Ronald E. Blaylock, and Scott Gottlieb. While insider ownership of Pfizer stock is relatively low at 0.06%, trading activity among its officers and directors, including acquisitions, sales, and option exercises, is regularly reported.
Join Stockcircle to see more insider trades and be the first to know about new executive transactions.
Sign UpTo improve your user experience we use cookies. Privacy Policy
Necessary for the website to function.
Help us understand how you use our site.
Used to show relevant ads.